School of Medicine
Showing 4,841-4,860 of 5,115 Results
-
Gerlinde Wernig
Associate Professor of Pathology
Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.
-
Marius Wernig
Professor of Pathology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine
-
Dee W. West
Professor of Health Research and Policy, Emeritus
Current Research and Scholarly Interests- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer
- Cancer surveillance (Cancer registration, cancer patterns)
- Cancer outcomes (Survival, quality of life, quality of care) -
Robert West
Sabine Kohler, MD, Professor of Pathology
Current Research and Scholarly InterestsRob West, MD, PhD, is a Professor of Pathology at Stanford University Medical Center. He is a clinician scientist with experience in translational genomics research to identify new prognostic and therapeutic markers in cancer. His research focus is on the progression of neoplasia to carcinoma. His lab has developed spatially oriented in situ methods to study archival specimens. He also serves as a surgical pathologist specializing in breast pathology.
-
M. Brandon Westover, MD, PhD
Instructor, Adult Neurology
BioDr. M. Brandon Westover is a board-certified, fellowship-trained epilepsy specialist, clinical neurophysiologist, and neurologist with Stanford Health Care. He is also an instructor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine and director of the Stanford Epilepsy Center.
Dr. Westover specializes in caring for adults with epilepsy and other neurological conditions. He focuses on developing automated tools that improve the quality and reach of his patients' care. He also treats patients with life-threatening unrelenting seizures (status epilepticus), reduced blood flow to the brain (cerebral ischemia), and reduced oxygen to the brain (anoxic brain injury). In addition, he helps patients experiencing delirium, seizures, and sleep disorders.
Dr. Westover's research develops artificial intelligence technology to protect and improve brain health. His interests include predicting seizures and detecting and forecasting disorders of memory, cognition, and consciousness—such as delirium and coma—in older adults. His work has also used deep learning to estimate the risk of developing epilepsy after a brain injury from brain-wave recordings (electroencephalograms, or EEGs).
Dr. Westover has published his research in leading peer-reviewed journals, including Neurology, JAMA Neurology, Annals of Neurology, Epilepsia, the Journal of the American Medical Informatics Association, and Lancet Digital Health. He has presented his work at international, national, and regional meetings, including the annual meetings of the American Epilepsy Society, the American Clinical Neurophysiology Society, the American Academy of Neurology, and SLEEP. -
Lynn Marie Westphal, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsInfertility, fertility preservation, oocyte cryopreservation
-
Cornelia Weyand
Professor of Medicine (Immunology and Rheumatology), Emerita
Current Research and Scholarly InterestsAutoimmunity
Chronic inflammatory disease
Metabolic control of immune function -
Matthew T. Wheeler
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsTranslational research in rare and undiagnosed diseases. Basic and clinical research in cardiomyopathy genetics, mechanisms, screening, and treatment. Investigating novel agents for treatment of hypertrophic cardiomyopathy and new mechanisms in heart failure. Cardiovascular screening and genetics in competitive athletes, disease gene discovery in cardiomyopathy and rare disease. Informatics approaches to rare disease and multiomics. Molecular transducers of physical activity bioinformatics.
-
Ian Whitmore
Professor (Teaching) of Surgery (Anatomy)
Current Research and Scholarly InterestsThe development of better regimes for teaching Anatomy using Cadavers.
-
Alice S Whittemore
Professor Emerita, Epidemiology and Population Health
Current Research and Scholarly InterestsCancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers.
-
Aileen Whyte, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Aileen Whyte, a licensed psychologist in California, brings over two decades of specialized expertise to the treatment of eating disorders in young people. Beyond her clinical practice, Dr. Whyte actively works on implementing strategies to expand the reach of evidence-based treatments for eating disorders, aiming to make these best-practice interventions more accessible to a wider population.
Dr Whyte serves as the Director of the Stanford Outpatient Child & Adolescent Eating Disorders Clinic, where she provides treatment to young people with eating disorders and provides supervision to psychology and psychiatry fellows. Dr Whyte is a certified practitioner and consultant in Family-Based Treatment (FBT) for eating disorders. She serves as a study therapist in NIMH-sponsored randomized clinical trials focused on examining FBT and related adaptations.
In addition to her clinical responsibilities, Dr. Whyte has led multiple seminars, workshops, and training sessions dedicated to the treatment of eating disorders. She provides ongoing training and consultation in FBT, reaching diverse audiences, including multidisciplinary clinicians, psychologists, and psychiatrists, within the US and internationally.
Dr. Whyte earned her PhD in Clinical Psychology from the New School for Social Research in New York. Her research and clinical interests converge on the implementation and dissemination of evidence-based treatments for eating disorders.
